Evaxion A/S Files Form 6-K for December 2025
Ticker: EVAX · Form: 6-K · Filed: Dec 19, 2025 · CIK: 1828253
| Field | Detail |
|---|---|
| Company | Evaxion A/S (EVAX) |
| Form Type | 6-K |
| Filed Date | Dec 19, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
Related Tickers: EVAX
TL;DR
Evaxion A/S (EVAX) filed a 6-K on 12/19/25, confirming it's a foreign private issuer reporting under Form 20-F.
AI Summary
Evaxion A/S, a biotechnology company, filed a Form 6-K on December 19, 2025, to report information for the month of December 2025. The filing indicates that the company is a foreign private issuer and will file its annual reports under Form 20-F. Evaxion A/S is incorporated in G7 and its principal executive office is located in Hoersholm, Denmark.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Evaxion A/S's ongoing reporting obligations as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine administrative report and does not contain new financial or operational information that would typically impact risk.
Key Numbers
- 001-39950 — SEC File Number (Identifies the company's filing history with the SEC.)
Key Players & Entities
- Evaxion A/S (company) — Registrant
- 20251219 (date) — Filing Date
- Hoersholm, Denmark (location) — Principal Executive Office Location
- Form 20-F (document) — Annual Report Filing Type
- Form 6-K (document) — Report Type
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information for the month of December 2025 as required by the U.S. Securities and Exchange Commission for foreign private issuers.
What is Evaxion A/S's SEC file number?
Evaxion A/S's SEC file number is 001-39950.
Where is Evaxion A/S's principal executive office located?
Evaxion A/S's principal executive office is located at Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark.
Under which form will Evaxion A/S file its annual reports?
Evaxion A/S will file its annual reports under cover of Form 20-F.
When was the company formerly known as Evaxion Biotech A/S?
The company was formerly known as Evaxion Biotech A/S, with a date of name change on October 14, 2020.
Filing Stats: 317 words · 1 min read · ~1 pages · Grade level 10.8 · Accepted 2025-12-19 07:15:06
Filing Documents
- f6k_121925.htm (6-K) — 7KB
- exh_991.htm (EX-99.1) — 6KB
- 0001171843-25-008026.txt ( ) — 14KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Evaxion A/S (Registrant) Date: December 19, 2025 By: /s/ Helen Tayton-Martin Helen Tayton-Martin Chief Executive Officer